Pyxis Oncology, Inc. (PYXS) Reports In-Line Q1 EPS

Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q1 EPS of ($0.37), in-line with the analyst estimate of ($0.37).

For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.

You May Also Be Interested In

• Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?
• Amazon cloud chief says inference demand is surging
• Piper Sandler Downgrades Bowhead Specialty Holdings (BOW) to Neutral